Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Trial of Ado-Trastuzumab Emtansine for Patients With HER2 Amplified or Mutant Cancers

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02675829
Recruitment Status : Active, not recruiting
First Posted : February 5, 2016
Last Update Posted : March 14, 2019
Sponsor:
Collaborator:
Genentech, Inc.
Information provided by (Responsible Party):
Memorial Sloan Kettering Cancer Center